Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 29

1.

Racial Differences in Cancer Susceptibility and Survival: More Than the Color of the Skin?

Özdemir BC, Dotto GP.

Trends Cancer. 2017 Mar;3(3):181-197. doi: 10.1016/j.trecan.2017.02.002. Epub 2017 Mar 6. Review.

PMID:
28718431
2.

Breast Cancer Disparities at Home and Abroad: A Review of the Challenges and Opportunities for System-Level Change.

Reeder-Hayes KE, Anderson BO.

Clin Cancer Res. 2017 Jun 1;23(11):2655-2664. doi: 10.1158/1078-0432.CCR-16-2630.

PMID:
28572260
3.

Assessing the Racial and Ethnic Disparities in Breast Cancer Mortality in the United States.

Yedjou CG, Tchounwou PB, Payton M, Miele L, Fonseca DD, Lowe L, Alo RA.

Int J Environ Res Public Health. 2017 May 5;14(5). pii: E486. doi: 10.3390/ijerph14050486. Review.

4.

Breast cancer survival disparity between African American and Caucasian women in Arkansas: A race-by-grade analysis.

Monzavi-Karbassi B, Siegel ER, Medarametla S, Makhoul I, Kieber-Emmons T.

Oncol Lett. 2016 Aug;12(2):1337-1342. Epub 2016 Jun 29.

5.

Breast cancers from black women exhibit higher numbers of immunosuppressive macrophages with proliferative activity and of crown-like structures associated with lower survival compared to non-black Latinas and Caucasians.

Koru-Sengul T, Santander AM, Miao F, Sanchez LG, Jorda M, Glück S, Ince TA, Nadji M, Chen Z, Penichet ML, Cleary MP, Torroella-Kouri M.

Breast Cancer Res Treat. 2016 Jul;158(1):113-26. doi: 10.1007/s10549-016-3847-3. Epub 2016 Jun 9.

6.

Ancestry dependent DNA methylation and influence of maternal nutrition.

Mozhui K, Smith AK, Tylavsky FA.

PLoS One. 2015 Mar 5;10(3):e0118466. doi: 10.1371/journal.pone.0118466. eCollection 2015.

7.

Associations of hormone-related factors with breast cancer risk according to hormone receptor status among white and African American women.

Cui Y, Deming-Halverson SL, Shrubsole MJ, Beeghly-Fadiel A, Fair AM, Sanderson M, Shu XO, Kelley MC, Zheng W.

Clin Breast Cancer. 2014 Dec;14(6):417-25. doi: 10.1016/j.clbc.2014.04.003. Epub 2014 Jun 2.

8.

Differences in gene and protein expression and the effects of race/ethnicity on breast cancer subtypes.

Chavez-Macgregor M, Liu S, De Melo-Gagliato D, Chen H, Do KA, Pusztai L, Fraser Symmans W, Nair L, Hortobagyi GN, Mills GB, Meric-Bernstam F, Gonzalez-Angulo AM.

Cancer Epidemiol Biomarkers Prev. 2014 Feb;23(2):316-23. doi: 10.1158/1055-9965.EPI-13-0929. Epub 2013 Dec 2.

9.

A phase 2 study of 16α-[18F]-fluoro-17β-estradiol positron emission tomography (FES-PET) as a marker of hormone sensitivity in metastatic breast cancer (MBC).

Peterson LM, Kurland BF, Schubert EK, Link JM, Gadi VK, Specht JM, Eary JF, Porter P, Shankar LK, Mankoff DA, Linden HM.

Mol Imaging Biol. 2014 Jun;16(3):431-40. doi: 10.1007/s11307-013-0699-7. Epub 2013 Oct 30.

10.

Disparities in breast cancer treatment and outcomes: biological, social, and health system determinants and opportunities for research.

Wheeler SB, Reeder-Hayes KE, Carey LA.

Oncologist. 2013;18(9):986-93. doi: 10.1634/theoncologist.2013-0243. Epub 2013 Aug 12.

12.

Cell Proliferation (KI-67) Expression Is Associated with Poorer Prognosis in Nigerian Compared to British Breast Cancer Women.

Agboola AO, Banjo AA, Anunobi CC, Salami B, Agboola MD, Musa AA, Nolan CC, Rakha EA, Ellis IO, Green AR.

ISRN Oncol. 2013 Apr 11;2013:675051. doi: 10.1155/2013/675051. Print 2013.

13.

Factors associated with receipt of breast cancer adjuvant chemotherapy in a diverse population-based sample.

Griggs JJ, Hawley ST, Graff JJ, Hamilton AS, Jagsi R, Janz NK, Mujahid MS, Friese CR, Salem B, Abrahamse PH, Katz SJ.

J Clin Oncol. 2012 Sep 1;30(25):3058-64. doi: 10.1200/JCO.2012.41.9564. Epub 2012 Aug 6.

14.

A population-based study of Kurdish breast cancer in northern Iraq: hormone receptor and HER2 status. A comparison with Arabic women and United States SEER data.

Runnak MA, Hazha MA, Hemin HA, Wasan AA, Rekawt RM, Michael HD.

BMC Womens Health. 2012 Jun 22;12:16. doi: 10.1186/1472-6874-12-16.

15.

Differential expression of breast cancer-associated genes between stage- and age-matched tumor specimens from African- and Caucasian-American Women diagnosed with breast cancer.

Grunda JM, Steg AD, He Q, Steciuk MR, Byan-Parker S, Johnson MR, Grizzle WE.

BMC Res Notes. 2012 May 22;5:248. doi: 10.1186/1756-0500-5-248.

16.

Race and the prognostic influence of p53 in women with breast cancer.

Dookeran KA, Dignam JJ, Holloway N, Ferrer K, Sekosan M, McCaskill-Stevens W, Gehlert S.

Ann Surg Oncol. 2012 Jul;19(7):2334-44. doi: 10.1245/s10434-011-1934-6. Epub 2012 Mar 21.

17.
18.

Interactions among genes, tumor biology and the environment in cancer health disparities: examining the evidence on a national and global scale.

Wallace TA, Martin DN, Ambs S.

Carcinogenesis. 2011 Aug;32(8):1107-21. doi: 10.1093/carcin/bgr066. Epub 2011 Apr 3. Review.

19.

A study to investigate the role of p27 and cyclin E immunoexpression as a prognostic factor in early breast carcinoma.

Pillay K, McCleod H, Chetty R, Hall P.

World J Surg Oncol. 2011 Mar 16;9:31. doi: 10.1186/1477-7819-9-31.

20.

Genome-wide copy number alterations in subtypes of invasive breast cancers in young white and African American women.

Loo LW, Wang Y, Flynn EM, Lund MJ, Bowles EJ, Buist DS, Liff JM, Flagg EW, Coates RJ, Eley JW, Hsu L, Porter PL.

Breast Cancer Res Treat. 2011 May;127(1):297-308. doi: 10.1007/s10549-010-1297-x. Epub 2011 Jan 25.

Supplemental Content

Support Center